Account
Inquiry
Tirzepatide 20mg is a novel peptide therapeutic agent that functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This innovative compound has shown significant potential in metabolic research applications.
The tirzepatide 20mg formulation demonstrates superior efficacy in glucose control compared to selective GLP-1 receptor agonists alone. Its unique dual mechanism of action combines the benefits of both GIP and GLP-1 receptor activation, making it particularly valuable for research into metabolic disorders.
Our tirzepatide 20mg is produced under strict quality control measures to ensure pharmaceutical grade purity (>99%). The white powder form offers excellent stability when stored properly, with a shelf life exceeding two years under recommended storage conditions.
Key features of our tirzepatide 20mg include: High biological activity, consistent batch-to-batch quality, and comprehensive analytical documentation. The product is supplied in sealed containers with desiccant to maintain stability during storage and transport.
As with all our research compounds, this tirzepatide 20mg product is intended for laboratory research use only. It is not for human consumption or diagnostic use. Researchers should handle all peptides with appropriate safety precautions in controlled laboratory settings.
The development of tirzepatide 20mg represents an important advancement in peptide-based metabolic research. Its dual agonist properties offer researchers new opportunities to study complex metabolic pathways and potential therapeutic applications.
For research institutions requiring larger quantities, we offer custom synthesis services for tirzepatide 20mg with flexible packaging options. Our manufacturing capabilities allow for scale-up production while maintaining the highest quality standards.
Note: This product is strictly for research purposes. Not for human or veterinary use.
